TAK-660-403

iOS app by ERT,INC. Medical · ERT,INC

Store rating
0 / 5
Store rating count
0
Download price
Free to download
In-app purchases
Unknown
Version
1.2
Listing last refreshed
2026-09-08

View the original store listing

Store description excerpt

An app for the TAK-660-403 Protocol. Evaluation of long-term safety of ADYNOVI / ADYNOVATE(Antihaemophilic Factor [Recombinant] PEGylated, rurioctocog alfa pegol) in patients with haemophilia A – An ADYNOVI / ADYNOVATE Post-Authorisation Safety Study (PASS)

Review coverage

AppRill has captured 0 reviews for this app. This is a collected sample, separate from the store rating count. Latest review capture: Not captured yet.

Recent captured chart positions

No chart positions have been captured for this app yet.

Chart position, rating count and review coverage do not establish downloads, revenue or profit. Understand the differences.